The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
This guidance provides a data‐supported approach to the diagnostic, therapeutic, and
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …
[PDF][PDF] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH)
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
Environmental factors sha** the gut microbiome in a Dutch population
The gut microbiome is associated with diverse diseases,–, but a universal signature of a
healthy or unhealthy microbiome has not been identified, and there is a need to understand …
healthy or unhealthy microbiome has not been identified, and there is a need to understand …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
Nonalcoholic steatohepatitis: a review
Importance Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic
fatty liver disease (NAFLD) and is associated with disease progression, development of …
fatty liver disease (NAFLD) and is associated with disease progression, development of …
[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel… - Journal of …, 2018 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
Nonalcoholic fatty liver disease 2020: the state of the disease
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …
Nonalcoholic fatty liver disease: a systematic review
ME Rinella - Jama, 2015 - jamanetwork.com
Importance Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis
affect approximately 30% and 5%, respectively, of the US population. In patients with …
affect approximately 30% and 5%, respectively, of the US population. In patients with …
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …